2019 Scientific Sessions

Interventional Pharmacology

Abbreviated DAPT: Current Practice and Contemporary Trials
Ajay J. Kirtane, M.D., FSCAI, Columbia University Medical Center, Demarest, NJ
What Is the Role for Cangrelor or GP IIB/IIIA Inhibitors in Today’s Practice?
Prospero B. Gogo, M.D., University of Vermont Medical Center, Burlington, VT
How to Switch to DAPT in 2019: Current Evidence and Recommendations
Kyung Woo Park, M.D., Ph.D., Seoul National University Hospital, Seoul, South Korea
Triple Therapy in 2019: Can I, When Do I, and Which Agent Do I Drop?
Amit N. Vora, M.D., FSCAI, Pinnacle Health Cardiovascular Institute, Enola, PA
Antiplatelet and Genetic Testing in 2019: Does a Need Exist?
George (Rick) A. Stouffer, M.D., UNC McAllister Heart Institute, Chapel Hill, NC
See more of: Coronary